In hepatocellular carcinoma (HCC) studies, RRBP1 has been shown to serve a key role in high glucose-mediated tumor malignant progression through the E2F transcription factor 1 (E2F1)/RRBP1 signaling pathway (42). Here, E2F1 is linked to neoplasm.